VIVUS, Inc. To Present At The Oppenheimer Diabetes Conference

MOUNTAIN VIEW, Calif., Sept. 15 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS - News), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products addressing obesity and sexual health, today announced that Timothy E. Morris, Vice President Finance and Chief Financial Officer, will present at the Oppenheimer Diabetes Conference. The conference will be held at the Jolly Hotel in New York City on Thursday, September 21st.

MORE ON THIS TOPIC